| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |